Cargando…

Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats

BACKGROUND: YangXinDingJi (YXDJ) capsule is one of traditional Chinese medicines (TCMs) derived from Zhigancao decoction, which is usually used for the treatment of cardiovascular disease in China. Aim of the Study. Cardiovascular events are one of the leading causes of death worldwide. Myocardial i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Miaomiao, Xue, Yurun, Liang, Yingran, Xue, Yucong, Han, Xue, Li, Ziliang, Chu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685838/
https://www.ncbi.nlm.nih.gov/pubmed/33281916
http://dx.doi.org/10.1155/2020/8539148
_version_ 1783613248015171584
author Liu, Miaomiao
Xue, Yurun
Liang, Yingran
Xue, Yucong
Han, Xue
Li, Ziliang
Chu, Li
author_facet Liu, Miaomiao
Xue, Yurun
Liang, Yingran
Xue, Yucong
Han, Xue
Li, Ziliang
Chu, Li
author_sort Liu, Miaomiao
collection PubMed
description BACKGROUND: YangXinDingJi (YXDJ) capsule is one of traditional Chinese medicines (TCMs) derived from Zhigancao decoction, which is usually used for the treatment of cardiovascular disease in China. Aim of the Study. Cardiovascular events are one of the leading causes of death worldwide. Myocardial ischemia (MI) severely reduces myocyte longevity and function. The YangXinDingJi (YXDJ) capsule has been used in the treatment of clinical cardiac disease in China. Nevertheless, the underlying cellular mechanisms for the benefits to heart function resulting from the use of this capsule are still unclear. The aim of this study was to evaluate the protective effects of the YXDJ on isoprenaline-induced MI in rats and to clarify its underlying myocardial protective mechanisms based on L-type calcium channels and myocardial contractility. MATERIALS AND METHODS: Rats were randomly divided into five groups with ten rats in each group: (1) control; (2) ISO-induced model; (3) high-dose YXDJ (2.8 g/kg/day intraperitoneally for five days), (4) low-dose YXDJ (1.4 g/kg/day for five days); and (5) verapamil (n = 10 in each group). Isoproterenol (ISO) was injected subcutaneously for two consecutive days to induce the rat model of MI. Heart and biochemical parameters were obtained. The patch-clamp technique was used to observe the regulatory effects of YXDJ on the L-type calcium current (I(Ca-L)) in isolated cardiomyocytes. An IonOptix MyoCam detection system was used to observe the contractility of YXDJ on isolated cardiomyocytes. RESULTS: YXDJ caused a significant improvement in pathological heart morphology and alleviated oxidative stress and inflammatory responses. Exposure to YXDJ caused a decrease in blockade of I(Ca-L) in a concentration-dependent manner. CONCLUSIONS: The results indicate that YXDJ significantly inhibited inflammatory cytokine expressions, oxidative stress, and L-type Ca(2+) channels, and decreased contractility in isolated rat cardiomyocytes. These findings may be relevant to the cardioprotective efficacy of YXDJ.
format Online
Article
Text
id pubmed-7685838
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-76858382020-12-04 Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats Liu, Miaomiao Xue, Yurun Liang, Yingran Xue, Yucong Han, Xue Li, Ziliang Chu, Li Evid Based Complement Alternat Med Research Article BACKGROUND: YangXinDingJi (YXDJ) capsule is one of traditional Chinese medicines (TCMs) derived from Zhigancao decoction, which is usually used for the treatment of cardiovascular disease in China. Aim of the Study. Cardiovascular events are one of the leading causes of death worldwide. Myocardial ischemia (MI) severely reduces myocyte longevity and function. The YangXinDingJi (YXDJ) capsule has been used in the treatment of clinical cardiac disease in China. Nevertheless, the underlying cellular mechanisms for the benefits to heart function resulting from the use of this capsule are still unclear. The aim of this study was to evaluate the protective effects of the YXDJ on isoprenaline-induced MI in rats and to clarify its underlying myocardial protective mechanisms based on L-type calcium channels and myocardial contractility. MATERIALS AND METHODS: Rats were randomly divided into five groups with ten rats in each group: (1) control; (2) ISO-induced model; (3) high-dose YXDJ (2.8 g/kg/day intraperitoneally for five days), (4) low-dose YXDJ (1.4 g/kg/day for five days); and (5) verapamil (n = 10 in each group). Isoproterenol (ISO) was injected subcutaneously for two consecutive days to induce the rat model of MI. Heart and biochemical parameters were obtained. The patch-clamp technique was used to observe the regulatory effects of YXDJ on the L-type calcium current (I(Ca-L)) in isolated cardiomyocytes. An IonOptix MyoCam detection system was used to observe the contractility of YXDJ on isolated cardiomyocytes. RESULTS: YXDJ caused a significant improvement in pathological heart morphology and alleviated oxidative stress and inflammatory responses. Exposure to YXDJ caused a decrease in blockade of I(Ca-L) in a concentration-dependent manner. CONCLUSIONS: The results indicate that YXDJ significantly inhibited inflammatory cytokine expressions, oxidative stress, and L-type Ca(2+) channels, and decreased contractility in isolated rat cardiomyocytes. These findings may be relevant to the cardioprotective efficacy of YXDJ. Hindawi 2020-11-17 /pmc/articles/PMC7685838/ /pubmed/33281916 http://dx.doi.org/10.1155/2020/8539148 Text en Copyright © 2020 Miaomiao Liu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liu, Miaomiao
Xue, Yurun
Liang, Yingran
Xue, Yucong
Han, Xue
Li, Ziliang
Chu, Li
Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_full Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_fullStr Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_full_unstemmed Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_short Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_sort mechanisms underlying the cardioprotection of yangxindingji capsule against myocardial ischemia in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685838/
https://www.ncbi.nlm.nih.gov/pubmed/33281916
http://dx.doi.org/10.1155/2020/8539148
work_keys_str_mv AT liumiaomiao mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT xueyurun mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT liangyingran mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT xueyucong mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT hanxue mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT liziliang mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT chuli mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats